13F
EN

COO COOPER COS INC/THE

2026Q1 · CUSIP 216648501 · 行业: 医疗与生物科技

转冷 · 广度回落
持有机构数
666
本季增减
+3
广度百分位
前 50%
大机构数
264
大机构增减
-3
机构持仓市值
$14.6B
新建仓
104
清仓
101
过去一季价格动量
-25.6%
Put / Call
6/6

广度历史(34 季度)

2024Q1: Δ+563 · h=566 2024Q2: Δ+53 · h=619 2024Q3: Δ+30 · h=649 2024Q4: Δ+24 · h=673 2025Q1: Δ-37 · h=636 2025Q2: Δ-17 · h=619 2025Q3: Δ+7 · h=626 2025Q4: Δ+37 · h=663 2026Q1: Δ+3 · h=666 2024Q1: holders=566 2024Q2: holders=619 2024Q3: holders=649 2024Q4: holders=673 2025Q1: holders=636 2025Q2: holders=619 2025Q3: holders=626 2025Q4: holders=663 2026Q1: holders=666 -563 -281.5 +0 +281.5 +563 509608707 24Q124Q224Q324Q425Q125Q225Q325Q426Q1 环比增减(柱) 持有机构数(线)

历次点亮与事后表现 共 4 次点亮

持仓期 百分位 其后 1 季收益 其后 2 季收益
2025Q4 前 14% -25.6% —
2024Q3 前 9% -11.1% -20.3%
2024Q2 前 3% +6.1% -8.2%
2024Q1 前 0% -2.1% +2.4%

期权情绪

Put 机构数
6
环比: -1
Call 机构数
6
环比: -1

查看方法论 →

基本面

PE(TTM)
59.0
EPS(TTM)
$1.17
EPS 同比
-43.5%
营收(TTM)
$4.2B
营收同比
+6.1%
近 4 年季度营收与 EPS
2022-07-31: $0.8B 2022-10-31: $0.8B 2023-01-31: $0.9B 2023-04-30: $0.9B 2023-07-31: $0.9B 2023-10-31: $0.9B 2024-01-31: $0.9B 2024-04-30: $0.9B 2024-07-31: $1.0B 2024-10-31: $1.0B 2025-01-31: $1.0B 2025-04-30: $1.0B 2025-07-31: $1.1B 2025-10-31: $1.1B 2026-01-31: $1.0B 2026-04-30: $1.1B 2022-07-31: EPS 0.49 2022-10-31: EPS 0.33 2023-01-31: EPS 0.43 2023-04-30: EPS 0.20 2023-07-31: EPS 0.43 2023-10-31: EPS 0.42 2024-01-31: EPS 0.41 2024-04-30: EPS 0.44 2024-07-31: EPS 0.52 2024-10-31: EPS 0.59 2025-01-31: EPS 0.52 2025-04-30: EPS 0.44 2025-07-31: EPS 0.49 2025-10-31: EPS 0.42 2026-01-31: EPS 0.66 2026-04-30: EPS -0.40 0B 0.5B 1.1B $B -0.44 0.14 0.73 2022202320242025202604/26 营收 EPS

季度申报值;EPS 已按拆股统一口径,无法校准的早期季度不展示

历史 PE(TTM)
4 年中位 55 2023-04-30: PE 63.32023-07-31: PE 61.62023-10-31: PE 61.42024-01-31: PE 69.12024-04-30: PE 552024-07-31: PE 62.12024-10-31: PE 48.22025-01-31: PE 38.72025-04-30: PE 33.72025-07-31: PE 31.92025-10-31: PE 44.12026-01-31: PE 35.22026-04-30: PE 57.6 29 51 73 20222023202420252026

PE = 季末后 47 天(财报公开日)收盘价 ÷ 当时 TTM EPS;亏损季不显示

数据截至 2026-04-30 · 来源 SEC 财报(XBRL)